Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arash Naghavi

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Prostate Cancer and Prostatic Diseases|July 12, 2020
Proof-of-principle Phase I results of combining nivolumab with brachytherapy and external beam radiation therapy for Grade Group 5 prostate cancer: safety, feasibility, and exploratory analysisZhigang Yuan, Daniel Fernandez, Jasreman Dhillon, et al.
JAMA Oncology|March 30, 2023
Pathologic Complete Response and Clinical Outcomes in Patients With Localized Soft Tissue Sarcoma Treated With Neoadjuvant Chemoradiotherapy or Radiotherapy: The NRG/RTOG 9514 and 0630 Nonrandomized Clinical TrialsDian Wang, Jonathan Harris, William G Kraybill, et al.
Cancer Medicine|July 7, 2022
Identifying and overcoming barriers to participation of minority populations in clinical trials: Lessons learned from the VanDAAM studyAngelina K C Fink, Amanda C DeRenzis, Shivanshu Awasthi, et al.
Journal for Immunotherapy of Cancer|May 4, 2026
Phase II trial of combination radiation, hormone, and immunotherapy in grade group 5 prostate cancerJohn Michael Bryant, Maria Sandoval, Ryan Putney, et al.
Journal of the National Cancer Institute|September 2, 2022
Genomic Testing in Localized Prostate Cancer Can Identify Subsets of African Americans With Aggressive DiseaseShivanshu Awasthi, G Daniel Grass, Javier Torres-Roca, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Prostate Cancer and Prostatic Diseases|July 12, 2020
Proof-of-principle Phase I results of combining nivolumab with brachytherapy and external beam radiation therapy for Grade Group 5 prostate cancer: safety, feasibility, and exploratory analysisZhigang Yuan, Daniel Fernandez, Jasreman Dhillon, et al.
JAMA Oncology|March 30, 2023
Pathologic Complete Response and Clinical Outcomes in Patients With Localized Soft Tissue Sarcoma Treated With Neoadjuvant Chemoradiotherapy or Radiotherapy: The NRG/RTOG 9514 and 0630 Nonrandomized Clinical TrialsDian Wang, Jonathan Harris, William G Kraybill, et al.
Cancer Medicine|July 7, 2022
Identifying and overcoming barriers to participation of minority populations in clinical trials: Lessons learned from the VanDAAM studyAngelina K C Fink, Amanda C DeRenzis, Shivanshu Awasthi, et al.
Journal for Immunotherapy of Cancer|May 4, 2026
Phase II trial of combination radiation, hormone, and immunotherapy in grade group 5 prostate cancerJohn Michael Bryant, Maria Sandoval, Ryan Putney, et al.
Journal of the National Cancer Institute|September 2, 2022
Genomic Testing in Localized Prostate Cancer Can Identify Subsets of African Americans With Aggressive DiseaseShivanshu Awasthi, G Daniel Grass, Javier Torres-Roca, et al.
Pageof 2